Home

blue

Ferring Announces Positive Topline Phase 3 Results for SI-6603

Read More

green

Four Analyses of Data for REBYOTA™ (fecal microbiota, live – jslm) Presented at DDW 2023

Read More

green

Retrospective Analysis of REBYOTA™ (fecal microbiota, live – jslm) Published in Open Forum Infectious Diseases

Read More

pink

Ferring Pharmaceuticals Recognizes National Infertility Awareness Week®

Read More

green

Ferring to Present Analyses of Data for REBYOTA™ (fecal microbiota, live – jslm) at DDW 2023

Read More

green

Ferring Announces Availability of REBYOTA™ (fecal microbiota, live – jslm)

Read More

U.S. FDA Approves Ferring’s Adstiladrin® (nadofaragene firadenovec-vncg)

Read More

green

Ferring Receives U.S. FDA Approval for REBYOTA (fecal microbiota, live-jslm)

Read More

Previous

Next

Helping mothers and babies, from conception to birth

At Ferring, we are committed to helping people become parents and to keeping mothers and babies healthy, from conception to birth. Over one third of our research and development investment goes towards finding innovative treatments in reproductive medicine and maternal health. We are also passionate about making a difference to people’s health and quality of life through our work in gastroenterology and orthopaedics.

icon box image

People & Families

icon box image

Science & Innovation

Believing in the power of research

Each of us at Ferring contribute to providing innovative solutions to help people live better lives. We devote significant research and development investment to new therapeutics, life cycle management and next generation healthcare solutions.

Join us

At Ferring Pharmaceuticals we highly value an attractive working environment that motivates our employees and stimulates the creative abilities and initiative of both individuals and teams. With over 6,000 employees in 56 countries, we are able to draw upon a large multicultural setting to enrich the work of our staff on all levels.

icon box image

Join us

icon box image

About Ferring

Helping people live better lives

Ferring Pharmaceuticals is a research-driven, specialty biopharmaceutical group committed to helping people around the world build families and live better lives. Ferring is a leader in reproductive medicine and maternal health, and in specialty areas within gastroenterology and orthopaedics. Ferring has been developing treatments for mothers and babies for over 50 years.

News